comparison of glp-1 agonists glp 1 How does Ozempic work? The Levels Guide to receptor agonists GLP-1 Receptor Agonist Market Size

Cardiovascular and renal outcomes with empagliflozin in heart failure

A cascade of laughter and, most importantly, improved glycemic control

Cell 185 , 24782494.e2428 (2022)

View image online ( stylized scientific illustration of hormone receptors For patients with type 2 diabetes and established cardiovascular disease, incretin-based therapy that targets both the GLP-1 and GIP gut hormones is associated with significantly greater cardiorenal benefits than therapy that targets GLP-1 alone

11,12,19 Liraglutide appears to have the highest proportion of severe GI AEs, and dulaglutide shows the lowest

This agent differs from earlier therapies that were designed to reduce myocardial loading or induce neurohumoral blockade